Speaker Hosted Roundtables

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Roundtable session lasts for 30 minutes and rotate

ROUNDTABLE 1: Comparator Sourcing in Small Biotech: Overcoming Limits with Strategic Outsourcing
ROUNDTABLE 2: Driving Efficiency and Results Through Strong Sponsor, CRO Partnerships

YongGwan Kim, Associate Director, Janssen

ROUNDTABLE 3: Key Areas to Focus on for Proactive Inspection Preparedness in Today’s Regulatory Landscape
ROUNDTABLE 4: Integrating Packaging and Labeling with Clinical Supply Chain Operations

Lunch and networking

Prize Draw taking place in exhibition hall at 14:15

Join us for a chance to win one of our prizes, including Apple products

Shifting Paradigms in the Treatment of Alzheimer’s Disease: AriBio and the Emergence of Korea’s First Global Blockbuster Candidate, AR1001

  • This presentation explores how AR1001 is poised to redefine the Alzheimer’s disease (AD) treatment landscape as a first-in-class, oral, disease-modifying therapy — bringing fresh momentum to a field that has seen limited progress over the past two decades
  • We will delve into the scientific breakthroughs and strategic learnings gained through years of innovation and perseverance within the highly challenging global AD space
  • Finally, we spotlight AriBio’s commitment to delivering the right therapy to the right patients at the right time, while upholding rigorous global regulatory and quality standards to support successful approvals in both the U.S. (FDA) and Europe (EMA)

Clinical Trials Surge in 2025

  • In H1, trial initiations significantly increased in comparison to previous years
  • Explore the latest trial trends, challenges, and opportunities for suppliers shaping clinical trials this year
  • See how this has shaken up the biopharma competitive landscape and how this will affect the clinical trial supply chain